Pricing analyst Jobs in Baar
(Sr) Manager, Market Access & Health Policy
BiogenBaar, Canton of Zug, Switzerland- Gesponsert
- Gesponsert
- Gesponsert
- Gesponsert
ASAP : FP&A Analyst 100%
Michael Page SuisseBaar, Kanton Zug, CH- Gesponsert
Legal Analyst (temporary)
kessler.vogler gmbhZugSenior Gas Analyst
MET GroupBaar, Canton of Zug, Switzerland- Gesponsert
SAP Financials Business Analyst (m / w / d)
bruederlinpartnerZug, CH- Gesponsert
Senior Business Intelligence Analyst
Johnson and JohnsonZug, CHScientist Lab Technician Assay Development (m / f / d)
HaysZug- Gesponsert
Projektleiter Sap Debitorenmanagement , 80-100%
emineo AGBaar, CHSystematic Vol Traders
Eka FinanceZug, SwitzerlandIndirect Tax Analyst
Canada GooseZug, CHStructure Analyst Cockpit
Resource GroupTurmstrasse, Zug, CHSr. Key Account Manager (all genders)
MarsZug, Zug, Switzerland(Sr) Manager, Market Access & Health Policy
BiogenBaar, Canton of Zug, Switzerland- Vollzeit
Job Description
For our offices in Baar, we are recruiting for a
Sr) Manager Market Access & Health Policy
About This Role :
The role of the (Sr) Manager, Market Access & Health Policy will play a pivotal role in ensuring our innovative treatments reach the patients who need them, which means :
- Ensuring that therapies within the Biogen portfolio are accessible and reimbursed for patients in Switzerland.
- Analyzing and anticipating changes in the evolving healthcare landscape and deriving strategic measures to influence and adapt to these changes.
This role involves a great deal of cross-functional collaboration across the affiliate and allows you to take on a very broad range of activities. It is key to apply a strategic approach and to establish and maintain an excellent relationship with external stakeholders such as the federal office of public health, health insurance companies, other external partners, and with internal stakeholders. This position is office-based but includes field activities.
Join Biogen as a Market Access & Health Policy (Sr) Manager and take on a role that combines strategic influence with impactful, patient-centered outcomes.
What You’ll Do :
Leads the compilation of the reimbursement dossiers, developing and implementing pricing strategies and new access models
Oversees price reviews by the FOPH and label changes
Conducts thorough analyses of health policy trends and their potential impacts on the Biogen portfolio
Establishes and maintains excellent relationships with relevant external stakeholders, such as the FOPH, health insurance companies, and other external partners through working-groups of trade associations or multi-stakeholder associations, as well as internal stakeholders
Who You Are :
You are a dynamic and strategic individual with the aim to continuously succeed in a complex and evolving landscape. Your strong scientific and analytical skillset allows you to guide and influence strategic decisions while always focusing on long-lasting and reliable relationship with internal and external stakeholders.
Required Skills :
Qualifications
Required Skills :
Additional Information
Why Biogen?
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about our DE&I efforts.